Anumana Collaborates with Leading Global Health Care Company to Detect Heart Disease Using Artificial Intelligence
Related Articles
Mayo Clinic helps launch two new companies for improved diagnostics
Mass Device: Mayo Clinic announced that it is introducing a new technology platform to support two new companies it has launched. Rochester, Minn.–based Mayo Clinic’s Remote Diagnostics & Management Platform…April 14, 2021
Cardiology’s AI Moment: Anumana’s Top Insights from ACC.25
#TeamAnumana wrapped up three incredible days of exploring cardiovascular science in the Windy City at the American College of Cardiology’s Annual Scientific Session. ACC.25 brought together thousands of cardiologists, investigators,…April 22, 2025
Anumana Collaborates with Novartis Pharmaceuticals Corporation
AI TechPark: Anumana, Inc., an AI-driven health technology company and portfolio company of nference, has launched a multi-year strategic collaboration with Novartis Pharmaceuticals Corporation (“Novartis”) to deploy a series of…July 13, 2022
Mayo Clinic finds algorithm helped clinicians detect heart disease, as part of broader AI diagnostics push
Med City News: Mayo Clinic shared results of a study showing that an AI tool developed by the system could be used to improve diagnosis of low ejection fraction, a…May 08, 2021